Clinical research is a rapidly evolving and dynamic environment
and the sector is undergoing significant changes on a number of
fronts. The wider use of technology, rapid advances in the diagnosis
and treatment of diseases such as cancer, and other emerging
health technologies such as data analytics, and the use of artificial
intelligence in diagnostics are having a significant impact on the
way that clinical trials are conducted. Martin Robinson at IAOCR
discusses how pharma companies are attempting to capitalise fully
on the data they collect from each study by having an increasing
number of trial objectives and consequently, clinical studies are
becoming more complex than ever before.